Optimal Timing for Repair of Left to Right Shunt Lesions

Related Clinical Trial
The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters Improving Care for Children With Congenital Heart Disease. Lifetech MFO Post-Market Clinical Follow-Up Study Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics Optical Tissue Identification for Myocardial Architecture Measures to Lower the Stress Response in Pediatric Cardiac Surgery Cardiac Function After Transcatheter VSD Closure The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure Closure of Muscular Ventricular Septal Defects (VSDs) With the AMPLATZER Muscular VSD (MuVSD) Occluder – Post Approval Study The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects. Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol Optimal Timing for Repair of Left to Right Shunt Lesions Use of Ketamine Prior to Cardiopulmonary Bypass in Children Aberrations in Carnitine Homeostasis in Congenital Heart Disease With Increased Pulmonary Blood Flow Transcatheter Closure Versus Surgery of Perimembranous Ventricular Septal Defects Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect Longterm Outcome After Ventricular Septal Defect Closure Closure of Perimembranous Ventricular Septal Defects With The AMPLATZER® Membranous VSD OCCLUDER Hybrid Closure of Congenital Heart Disease

Brief Title

Optimal Timing for Repair of Left to Right Shunt Lesions

Official Title

Optimal Timing for Repair of Left-to-Right Shunt Lesions

Brief Summary

      The purpose of this study is to determine the optimal timing for repair of left-to-right
      shunt lesions such as ventricular septal defects and atrioventricular canals.
    

Detailed Description

      In the past, children with left-to-right shunt lesions such as ventricular septal defects and
      atrioventricular canal defects were palliated with a pulmonary artery band. This prevented
      injury to the pulmonary vasculature while the child grew to a size where complete repair
      could be undertaken. With the improvements in surgical technique and critical care, there is
      a push to do a primary complete repair for these defects at younger and younger ages. These
      operations should be delayed as long as possible to allow for growth but not so long that
      there is unnecessary heart failure and medication requirements. The primary aim is to
      determine the optimal timing for repair of left-to-right shunt lesions such as ventricular
      septal defects and atrioventricular canals. The secondary aim is to define the criteria for
      failing medical anti-congestive heart failure therapy. This study will be conducted through a
      retrospective chart review.
    


Study Type

Observational




Condition

Ventricular Septal Defects



Publications

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information



Estimated Enrollment

200

Start Date

May 2005

Completion Date

August 2007


Eligibility Criteria

        Inclusion Criteria:

          -  Patients in the congenital surgery database

          -  Patients who have undergone repair of ventricular septal defects

          -  Patients who have undergone repair of atrioventricular canal defects
      

Gender

All

Ages

N/A - N/A

Accepts Healthy Volunteers

No

Contacts

Brian Kogon, MD, , 

Location Countries

United States

Location Countries

United States

Administrative Informations


NCT ID

NCT00229827

Organization ID

05-092



Study Sponsor

Children's Healthcare of Atlanta


Study Sponsor

Brian Kogon, MD, Principal Investigator, Emory University


Verification Date

May 2007